Nanjing Nuoling Biological Technology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nanjing Nuoling Biological Technology Co., Ltd. - overview
Established
2018
Location
Nanjing, Jiangsu, China
Primary Industry
Medical Devices & Equipment
About
Established in 2018 and based in Nanjing, China, Nanjing Nuoling Biological Technology Co. , Ltd. is a medical device company that focuses on the research and development of novel medical devices. The company has set up R&D and production headquarters in Nanjing and a medical market center in Beijing.
Wen Mao, the company's founder and CEO, has served as a senior executive at Abbott's U. S. headquarters for 6 years and the head of precision medicine for the World Economic Forum in Davos, China. In April 2025, it closed a series C funding.
The company's main products include portable NO therapy devices, NO wound gas therapy devices and exhaled NO detectors. Its products are used in diseases such as pulmonary hypertension, diabetic foot and COPD. Nanjing Nuoling Biological Technology Co. , Ltd.
generates revenue by providing its innovative medical devices and related services to the healthcare industry. The company will use the series C funding to expand the production capacity, commercialize and expand overseas of the company's portable NO inhalation therapy device.
Current Investors
InnoMed Capital, NLVC, Lilly Asia Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Medical Equipment Distributors
Website
www.novlead.com
Verticals
Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.